APIC’s 2019 Virtual Conference

Dec 12, 2019 ‐ Dec 12, 2019



Sessions

APIC's 2019 Virtual ConferenceAPIC's 2019 Virtual Conference

Preview Available

APIC's 2019 Virtual Conference

Dec 12, 2019 11:30am ‐ Dec 12, 2019 3:35pm

Identification: APIC19

Join us online for APIC’s inaugural 2019 Virtual Conference on December 12. This ground-breaking new event gives you an unique chance to access the fundamental learning that all IPs need. With a variety of sessions offered over four hours, you’ll hear from thought leaders and practitioners in the field of IPC in an interactive learning platform that’s convenient, cost-effective, and accessible from any device! Sessions include:

  • SSI Prevention Strategies: IP in the OR | Hilary Babcock, MD, MPH and Karen Hoffmann, RN, MS, CIC, FSHEA, FAPIC
  • Construction and Infection Prevention: Using the Tools to Your Advantage | Leon Young, B.S. MT, ASCP
  • Peripheral Vascular Access Device Infection: An Urgent Patient Safety Issue| Marcia A. Ryder, PhD, MS, RN
  • From Plumbing to Patients: Current and Future CDC Activities to Reduce Risk from Water in Healthcare| Matthew J. Arduino, DrPH, MS, RM(NRCM), M(ASCP)CM, FSHEA and Matthew J. Stuckey, PhD, MPH
  • Preparing for Candida auris: Infection Prevention for a Transmissible Fungus | Meghan Lyman, MD

Speaker(s):
  • Hilary Babcock, MD, MPH, Professor of Medicine, Division of Infectious Disease; Medical Director of Occupational Health for Barnes Jewish and St. Louis Children’s, Washington University School of Medicine; BJC Health Care
  • Karen Hoffmann, RN, MS, CIC, FSHEA, FAPIC, Clinical Instructor, Division of Infectious Diseases, University of North Carolina
  • Leon Young, B.S. MT, ASCP, Improvement Specialist, Infection Prevention/Construction, University of Pittsburgh Medical Center Corporate Services
  • Marcia Ryder, PhD, MS, RN , Research Scientist, RyderScience, Inc.
  • Matthew J. Arduino, MS, DrPH, FSHEA, M(ASCP), Senior Advisor, Environmental Hygiene and Infection Prevention, Centers for Disease Control and Prevention
  • Matthew J. Stuckey, PhD, MPH, Epidemiologist, Division of Healthcare Quality
  • Meghan Lyman

SSI Prevention Strategies: IP in the OR

Dec 12, 2019 11:40am ‐ Dec 12, 2019 12:40pm

Identification: FRI01

The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the U.S. continues to rise, and surgical patients are initially seen with increasingly complex co-morbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies. There are specific requirements to minimize the spread of microorganisms and maintain sterility in the operating room (OR) environment. This presentation will review the challenges and issues as well as guidelines and standards affecting the OR setting. You will learn:

  • New and updated evidence-based recommendations for the prevention of SSI
  • How to identify activities in the OR that increase SSI risk
  • Understand OR challenges for IP
  • Understand updates from recent SSI guidelines

Speaker(s):
  • Hilary Babcock, MD, MPH, Professor of Medicine, Division of Infectious Disease; Medical Director of Occupational Health for Barnes Jewish and St. Louis Children’s, Washington University School of Medicine; BJC Health Care
  • Karen Hoffmann, RN, MS, CIC, FSHEA, FAPIC, Clinical Instructor, Division of Infectious Diseases, University of North Carolina

Construction and Infection Prevention: Using the Tools to Your Advantage

Dec 12, 2019 12:45pm ‐ Dec 12, 2019 1:25pm

Identification: FRI02

As hospitals and LTC facilities age or seek ways to improve their patient care capabilities, there is often an increase in construction and maintenance activities. During these projects, the IP must remain focused on patient safety and the Infection Control Risk Assessment (ICRA).

This session will cover procedures that are essential to assuring patient safety during construction and maintenance activities. Topics to be discussed will include everything from completing an ICRA permit to how to conduct project rounding to identify what is right and what is wrong. This session will also briefly cover the use of a handheld particle counter that can be of benefit to the IP during a construction project. Discussions will revolve around how a particle counter can be used to enhance construction project rounding and monitoring. You will learn how to:

  • Describe how to plan and implement construction containment based on the Infection Control Risk Assessment (ICRA) and ICRA permit.
  • Conduct construction project rounding with the confidence and education needed to solve problems.
  • Demonstrate the benefits of using a handheld particle counter.

Speaker(s):
  • Leon Young, B.S. MT, ASCP, Improvement Specialist, Infection Prevention/Construction, University of Pittsburgh Medical Center Corporate Services

Peripheral Vascular Access Device Infection: An Urgent Patient Safety Issue

Dec 12, 2019 1:30pm ‐ Dec 12, 2019 2:30pm

Identification: FRI03

The success of most medical acute and chronic life-sustaining therapies across all ages and patient populations is dependent on reliable vascular access. Though critical to the provision of life-saving medical therapies, vascular access devices (VADs) are associated with significant risk. Under-reported, under-recognized, and most often ignored, are the infections associated with peripheral vascular access devices (PVADs), such as short peripheral catheters (SPC) and midline catheters (MC). From 2008 to 2011, hospitals across the nation made significant progress in preventing CLABSI, achieving ~50% reduction in those three years. However, the rate of CLABSI has not improved since 2015 despite concerted efforts. The expectation is that CLABSI will decrease significantly by 2020. If IPs cannot identify unrecognized risk factors such as PVAD-BSI that contribute to the flat line in progress, this task may be insurmountable.

Consider the answers to these questions: Do you know your institution’s PVAD incidence rate for BSI? How many of your CLABSIs are PVAD-BSI? How do you diagnose PVAD-BSI? Will clinically indicated SPC site changes increase the risk for SPC-BSI and what are the legal implications? Have you considered that non-sterile insertion of SPCs may increase BSI risk? Have you considered the lack of sterile SPC insertion as a legal liability when all other VADs are inserted with sterile technique? Do we want to continue to ignore the risk of perpetuating antibiotic resistance by the increasing need to treat the very devices we use to treat non-device related infections? Is the use of MCs to avoid CLABSI in the best interest of the patient? You will get answers to these questions and will learn how to:

  • Evaluate the gaps in the current standards of care for PVADs and consider pathophysiologic-based strategies to improve PVAD patient safety.
  • Examine the consequences of replacing central venous access with peripheral venous access to avoid CLABSI penalty.
  • Identify the growing and under-appreciated malpractice risks surrounding PVADs and develop risk management strategies which meet the standard of care and can mitigate liability.

Speaker(s):
  • Marcia Ryder, PhD, MS, RN , Research Scientist, RyderScience, Inc.

From Plumbing to Patients: Current and Future CDC Activities to Reduce Risk from Water in Healthcare

Dec 12, 2019 2:35pm ‐ Dec 12, 2019 3:15pm

Identification: FRI04

Staff from the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention discuss recent activities related to outbreaks of water-associated pathogens and trends in water management programs. This session focuses on water-associated outbreaks, drawing on such data sources PRB outbreak consultations about water-associated outbreaks, and NHSN annual facility survey data for hospitals and nursing homes about current status of water management plans and control activities. You will learn how to:

  • Identify different opportunistic pathogens of premise plumbing and consider various transmission pathways.
  • Recognize the role of water infection control risk assessments in water management programs.
  • Locate additional online CDC resources for water management programs in healthcare settings.

Speaker(s):
  • Matthew J. Stuckey, PhD, MPH, Epidemiologist, Division of Healthcare Quality
  • Matthew J. Arduino, MS, DrPH, FSHEA, M(ASCP), Senior Advisor, Environmental Hygiene and Infection Prevention, Centers for Disease Control and Prevention

Preparing for Candida auris: Infection Prevention for a Transmissible Fungus

Dec 12, 2019 3:20pm ‐ Dec 12, 2019 3:50pm

Identification: FRI05

The emerging drug-resistant fungus Candida auris is a yeast that breaks the mold. From an infection prevention perspective, it behaves more like bacteria in its ability to colonize skin, survive on healthcare surfaces, and spread between patients, causing outbreaks.

This session will cover what we know—and what we don’t—about C. auris and current recommendations for early detection and infection prevention. In particular, it will cover the similarities and differences in containing spread of C. auris vs. other multidrug-resistant organisms and address common myths. You will learn:

  • What to do if a C. auris case is detected in your facility
  • The key interventions for preventing spread
  • Some of the known unknowns about this emerging pathogen

Speaker(s):
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content